Stock Earnings
Analysts review Longboard Pharmaceuticals Inc’s rating
In a filing, Longboard Pharmaceuticals Inc revealed its CMO Kaye Randall unloaded Company’s shares for reported $0.53 million on Sep
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.